What side effects should I expect from GLP-1 therapy
The first five digits identify the manufacturer of the drug and are assigned by the U.S
At 68 weeks, the treatment-regimen estimand results were -20.0% (9 mg dose, approximately 50.5 pounds) and -23.7% (12 mg dose, approximately 60 pounds)
How PlexusDx Supports a More Personalized Approach PlexusDx's approach to compounded medication management integrates biomarker and genetic context with practical safety protocols
It's important to note that while Ozempic is licensed for type 2 diabetes, Wegovy (a higher-dose semaglutide product) is specifically licensed for weight management
Side effects were consistent with the GLP-1 drug class, including nausea, diarrhea, and vomiting